# Observational Rare Diseases studies recruiting: 72 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 72 trials that are observational for Rare Diseases that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Rare Diseases studies: 72 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/rare-diseases

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 72
- Recruiting or not yet: 72
- Read on: November 19, 2026

## Trials

The 25 newest of 72, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07922447 | Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National... | University Hospital, Toulouse | Observational | Not yet recruiting | Superior Semicircular Canal Dehiscence | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922447) |
| October 30, 2026 | NCT07906639 | A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting Elafibranor | Ipsen | Observational | Not yet recruiting | Primary Biliary Cholangitis (PBC) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906639) |
| October 20, 2026 | NCT07884227 | Multi-Omics Genetic Investigation Strategies to Enhance the Diagnostic Workflow for Rare Diseases | Istituto Giannina Gaslini | Observational | Recruiting | Neurodevelopmental Disorders, Intellectual Disability, Autism Spectrum Disorder, Genetic Diseases, Inborn | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884227) |
| October 1, 2026 | NCT07851844 | Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Genetic and Inflammatory Polyneuropathies | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07851844) |
| September 24, 2026 | NCT07839754 | EpiSign International: Expanding Epigenomic Testing in Rare Disease | University of Manchester | Observational | Not yet recruiting | Rare Disease, Undiagnosed Disease, Genetic Diseases, Inborn, Congenital Abnormalities | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839754) |
| September 2, 2026 | NCT07799792 | Implementation-effectiveness Trial of Mainstreaming of Clinical Genomic Sequencing for Rare Disease in Ontario, Canada | The Hospital for Sick Children | Observational | Not yet recruiting | Evaluation of Mainstreamed Models of Genetic Service Delivery, Genetic Disease, Neurodevelomental Disorders | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799792) |
| July 30, 2026 | NCT07737756 | A Real-World Medical Chart Review of Spinal Muscular Atrophy Patients Treated With Onasemnogene Abeparvovec in Saudi Arabia | Novartis Pharmaceuticals | Observational | Not yet recruiting | Spinal Muscular Atrophy | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737756) |
| July 28, 2026 | NCT07731971 | Digital Outcome Assessment Using AI Active Gaming and Motion Capture in Friedreich Ataxia | University of Exeter | Observational | Not yet recruiting | Friedreich Ataxia | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731971) |
| April 29, 2026 | NCT07556913 | Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy | Ipsen | Observational | Recruiting | Pregnancy Related | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07556913) |
| April 14, 2026 | NCT07527624 | Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability | Imagine Institute | Observational | Recruiting | Rare Diseases | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07527624) |
| March 27, 2026 | NCT07497581 | A Longitudinal Study on Family Adaptation and Relationship Dynamics in Pediatric Rare Diseases | Sponsor not shown (see the record) | Observational | Not yet recruiting | Rare Diseases | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07497581) |
| February 20, 2026 | NCT07422454 | FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects | Imagine Institute | Observational | Recruiting | Craniofacial Abnormalities | 3,100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07422454) |
| February 10, 2026 | NCT07400913 | Implementation of Long-read Sequencing for the Diagnosis of Rare Diseases. | University Hospital, Bordeaux | Observational | Not yet recruiting | Rare Diseases, Albinism, Intellectual Disability | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400913) |
| February 5, 2026 | NCT07391293 | Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors. | IRCCS Policlinico S. Donato | Observational | Recruiting | Thoracic Aortic Aneurysm (TAA) | 208 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07391293) |
| January 28, 2026 | NCT07374107 | MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) | Myositis International Health & Research Collaborative Alliance Foundation | Observational | Recruiting | IBM, IIM, Myositis, Inflammatory Myopathy, Dermatomyositis, Dermatomyositis, Juvenile, Anti-synthetase Syndrome... | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374107) |
| January 23, 2026 | NCT07362225 | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative... | MPN Research Foundation | Observational | Recruiting | Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362225) |
| January 2, 2026 | NCT07314736 | Stakeholders of Rare Diseases Informing Values In Neuroethics | St. Jude Children's Research Hospital | Observational | Recruiting | Rare Disorder, Disorder, Neurologic | 385 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07314736) |
| November 25, 2025 | NCT07247279 | Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia | AstraZeneca | Observational | Recruiting | Rare Diseases, Generalized Myasthenia Gravis (gMG) | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07247279) |
| October 3, 2025 | NCT07205861 | Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Thrombotic Thrombocytopenic Purpura (TTP), Immune Thrombotic Thrombocytopenic Purpura, Thrombotic Microangiopathies... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07205861) |
| August 29, 2025 | NCT07147465 | Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients | Assistance Publique - Hôpitaux de Paris | Observational | Recruiting | Cancer, NGS, Tumor, RARE DISEASE | 3,149 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07147465) |
| August 19, 2025 | NCT07130071 | Channelling Algorithm Proficiency To Understand, Recognise and Elucidate Disease | Research in Real-Life Ltd | Observational | Not yet recruiting | Rare Disorders | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07130071) |
| August 19, 2025 | NCT07128966 | Direct to Patient Minimal Risk Biospecimen and Data Collection Research | Sponsor not shown (see the record) | Observational | Recruiting | Healthy, Lupus, Celiac, Kidney Disease, Chronic, Dermatologic | 100,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07128966) |
| August 17, 2025 | NCT07127978 | A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy | ITF Therapeutics LLC | Observational | Recruiting | Duchene Muscular Dystrophy | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07127978) |
| May 13, 2025 | NCT06969209 | Brain Aging in Phenylketonuria | Insel Gruppe AG, University Hospital Bern | Observational | Recruiting | Phenylketonuria (PKU) | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06969209) |
| March 12, 2025 | NCT06871696 | Genetic of Intellectual Deficiency and Autism Spectrum Disorders (RaDiCo-GenIDA) | Institut National de la Santé Et de la Recherche Médicale, France | Observational | Recruiting | Genetic of Intellectual Deficiency, Autism Spectrum Disorder | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06871696) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| IRCCS Policlinico S. Donato | 5 |
| National Human Genome Research Institute (NHGRI) | 5 |
| Assistance Publique - Hôpitaux de Paris | 4 |
| University Hospital Tuebingen | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 3 |
| Imagine Institute | 3 |
| [Ipsen](https://specstream.ai/data/clinical-trials/company/ipsen) | 3 |
| Boston Children's Hospital | 2 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| University Hospital, Bordeaux | 1 |
| Research in Real-Life Ltd | 1 |
| University Hospital Freiburg | 1 |
| Hospital Italiano de Buenos Aires | 1 |
| MPN Research Foundation | 1 |
| Epilepsy Foundation of America | 1 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| Minovia Therapeutics Ltd. | 1 |
| University of Missouri-Columbia | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 1 |
| Akcea Therapeutics | 1 |
| ITF Therapeutics LLC | 1 |
| University of Exeter | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 23 |
| France | 14 |
| Italy | 12 |
| Germany | 9 |
| Switzerland | 3 |
| United Kingdom | 3 |
| Israel | 2 |
| Brazil | 2 |
| Canada | 2 |
| Argentina | 1 |
| Russia | 1 |
| Romania | 1 |
| Ukraine | 1 |
| Colombia | 1 |
| Australia | 1 |
| Austria | 1 |
| Belgium | 1 |
| Czechia | 1 |
| Greece | 1 |
| India | 1 |
| Ireland | 1 |
| Netherlands | 1 |
| New Zealand | 1 |
| Spain | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Resorts in the United States](https://specstream.ai/data/businesses/resorts/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Coworking spaces in the United States](https://specstream.ai/data/businesses/coworking-spaces/united-states)
- [Window installers in the United States](https://specstream.ai/data/businesses/window-installers/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
- [Home automation companies in the United States](https://specstream.ai/data/businesses/home-automation-companies/united-states)
